CXCL8 is a pleiotropic signaling molecule known to mediate CAF promotion of angiogenesis, EMT, and the recruitment of myeloid-derived suppressor cells and tumor-associated neutrophils (57, 58). This evidence concerns the gene CXCL8 and neoplasm.